PUBLICATIONS · 34516954
Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Lancet Oncol
- Publication date
- 2021 Oct
- First author
- Schuster SJ
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Nat Rev Clin Oncol. 2021 Nov;18(11):676. doi: 10.1038/s41571-021-00567-0.
- note
- Source null
- related pmid
- 34580475
- relationship
- Comment in
Authors and identifiers
- name
- Schuster SJ
- type
- Author
- name
- Tam CS
- type
- Author
- name
- Borchmann P
- type
- Author
- name
- Worel N
- type
- Author
- name
- McGuirk JP
- type
- Author
- name
- Holte H
- type
- Author
- name
- Waller EK
- type
- Author
- name
- Jaglowski S
- type
- Author
- name
- Bishop MR
- type
- Author
- name
- Damon LE
- type
- Author
- name
- Foley SR
- type
- Author
- name
- Westin JR
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Schuster SJ
- type
- Author
- name
- Tam CS
- type
- Author
- name
- Borchmann P
- type
- Author
- name
- Worel N
- type
- Author
- name
- McGuirk JP
- type
- Author
- name
- Holte H
- type
- Author
- name
- Waller EK
- type
- Author
- name
- Jaglowski S
- type
- Author
- name
- Bishop MR
- type
- Author
- name
- Damon LE
- type
- Author
- name
- Foley SR
- type
- Author
- name
- Westin JR
- type
- Author
- bibliography ids
- nci-bib-2c0b6dee4d18d4026858ac79
- book metadata
- content sha256
- 2e17d7d6ab035211f76ff123e7778dad74a3eb7a121f23c1abe8e64d7b24d933
- document type
- citation
- dois
- 10.1016/S1470-2045(21)00375-2
- electronic publication date
- display
- 2021 Sep 10
- precision
- day
- year
- 2021
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:34516954
- immutable id
- pubmed:34516954@2e17d7d6ab035211f76ff123e7778dad74a3eb7a121f23c1abe8e64d7b24d933
- journal
- abbreviation
- Lancet Oncol
- issn electronic
- 1474-5488
- issn print
- 1470-2045
- issue
- 10
- name
- The Lancet. Oncology
- nlm unique id
- 100957246
- pages
- 1403-1415
- volume
- 22
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- citation
- Nat Rev Clin Oncol. 2021 Nov;18(11):676. doi: 10.1038/s41571-021-00567-0.
- note
- Source null
- related pmid
- 34580475
- relationship
- Comment in
- outcomes validated
- false
- pmid
- 34516954
- provenance
- batch id
- 192b6392c165c6b06274
- provider
- NCBI PubMed ESummary
- record sha256
- de3816966a89410d5d4ad36d1ca0cd919c8b2e89a35b58cc077654e16688864d
- response sha256
- 7d81e9fb11ee99e6ad4116aecd61ba71cd6bf76f2a8f8f6d15c5c85e9c6c56b4
- retrieved at
- 2026-09-09T23:48:02.713075+00:00
- publication date
- display
- 2021 Oct
- precision
- month
- year
- 2021
- publication types
- Clinical Trial, Phase II
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Long-term clinical outcomes of tisagenlecleucel in patients with relapsed or refractory aggressive B-cell lymphomas (JULIET): a multicentre, open-label, single-arm, phase 2 study.
Preserved source evidence · Independent clinical review pending · Not medical advice
Triangle